SCHEMBL3413334

SCHEMBL3413334

CCC(Cc1cccc(-c2ccc(OC)c(CNC(=O)c3ccc(Cl)cc3Cl)c2)c1)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 20/20 0.63
PPARG P37231 12/20 0.63
PPARD Q03181 11/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3417664 0.89 PPARA (0.58) PPARAPPARGPPARD
SCHEMBL13460859 0.87 PPARA (0.47) PPARAPPARGPPARD
SCHEMBL13433426 0.86 PPARD (0.47) PPARAPPARGPPARD
SCHEMBL3413759 0.84 PPARD (0.49) PPARAPPARGPPARD
SCHEMBL3418675 0.82 PPARA (0.83) PPARAPPARGPPARD
SCHEMBL3414230 0.82 PPARA (0.63) PPARAPPARGPPARD
SCHEMBL13460766 0.81 PKM (0.44) PPARAPPARGPPARD
SCHEMBL3416041 0.79 LMNA (0.50) PPARAPPARGPPARD
SCHEMBL13460821 0.79 PPARG (0.46) PPARAPPARGPPARD
SCHEMBL3411792 0.79 ACLY (0.48) PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687664-B2 Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-03-30 US disclosed
US-7687664-B2 Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-03-30 US disclosed
US-20040214888-A1 Carboxylic acid derivative and medicine comprising salt or ester of the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-10-28 US disclosed
EP-1394147-A1 CARBOXYLIC ACID DERIVATIVE AND MEDICINE COMPRISING SALT OR ESTER OF THE SAME Eisai Co., Ltd. (JP) 2004-03-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040214888-A1 Carboxylic acid derivative and medicine comprising salt or ester of the same GPR119, NR3C1, INSR PPARA 130/4885PPARG 238/4885PPARD 689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.